Trial Condition(s):

N/A

SD/MD study in Chinese,BAY1192631, ICPP

Bayer Identifier:

16411

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
N/A
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
No
Products
Sivextro (Tedizolid phosphate, BAY119-2631)
Accepts Healthy Volunteers
N/A

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Beijing, China, 100730

Status
Completed
 

For details, please refer to trial results

Additional Information